Nano Textile was established in 2013, immediately after a very successful R&D phase, which was fully funded by a 12M EURO investment from the European Commission’s FP7 initiative.
Nano Textile has developed a breakthrough, single-step nano-coating process, which is done via an IP protected sonochemistry reactor. The process, despite its innovative brilliancy, is very cost-effective.
Nano Textile's main objective, and the catalyst for our innovation, is to prevent the unnecessary loss of lives due to hospital-acquired infections.
The company's unique and breakthrough single-step nano-coating process has proven itself to be the only viable anti-bacterial solution in the world for hospitals due to the extreme durability of the anti-bacterial properties and the limitless manufacturing abilities. Therefore, it allows Nano Textile to implement its technology into any kind of fabric, either man-made or natural, with absolutely no damage or alteration to the fabrics’ original quality or color.
Nano Textile currently holds granted patents in Israel, the US, and the EU and holds patent pending requests in additional strategic markets around the world.
Although its main target is providing antibacterial nano-coating services to hospital textile manufacturers, the company's technology allows it to coat any kind of surface, from glass, to ceramic, to polymers, and implement not only antibacterial properties, but additional properties such as magnetic, electric conductivity and super-hydrophobic properties.